Summary
Concentrations of organic acids in cerebrospinal fluid (CSF) appear to be directly dependent upon their rate of production in the brain. There is evidence that the net release of short-chain monocarboxylic acids from the brain is a major route for removing these products of cerebral metabolism. Concentrations of organic acids in blood and CSF are largely independent of each other. Quantitative reference values for the concentrations of organic acids in CSF and plasma as well as ratios of individual organic acids between CSF and plasma were determined in 35 pairs of samples from paediatric patients. Over 25 organic acids were quantifiable in all or in the majority of CSF and/or plasma specimens (limit of detection 1 µmol/L). There were substantial differences in the CSF/plasma ratios between subgroups of organic acids. Metabolites related to fatty-acid oxidation were present in CSF in substantially less amounts than in plasma. Organic acids related to carbohydrate and energy metabolism and to amino acid degradation were present in CSF in the same amounts as or slightly smaller amounts than in plasma. Finally, some organic acids were found in substantially higher amounts in CSF than in plasma, e.g. glycolate, glycerate, 2,4-dihydroxybutyrate, citrate and isocitrate.
Studies of organic acids in CSF and plasma samples are presented from patients with ‘cerebral’ lactic acidosis, disorders of propionate and methylmalonate metabolism, glutaryl-CoA dehydrogenase deficiency andl-2-hydroxyglutaric acidura. It became apparent that derangements of organic acids in the CSF may occur independently of the systemic metabolism. Quantitative organic acid analysis in CSF will yield new information on the pathophysiology in the central nervous system (CNS) of these disorders and may prove necessary for successful monitoring of treatment of organoacidopathies, which present mainly with neurological disease. For example, in glutaryl-CoA dehydrogenase deficiency the urinary excretion of glutarate appears to be an inadequate parameter for monitoring the effect of dietary therapy, without plasma and CSF determinations. Inl-2-hydroxyglutaric aciduria the elevation ofl-2-hydroxyglutarate was found to be greater in CSF than in plasma. In addition, some other organic acids, glycolate, glycerate, 2,4-dihydroxybutyrate, citrate and isocitrate, were also elevated in the CSF of the patients out of proportion to normal levels in plasma and urine. High concentrations of an unknown compound, which was tentatively identified as 2,4-dihydroxyglutarate, were found in the CSF of patients withl-2-hydroxyglutaric aciduria. Quantitative determination of organic acids in CSF and plasma should aid the monitoring of treatment of patients with organic acid disorders, allow investigations of metabolites in known disorders, and detect neurometabolic diseases in which the diagnostic metabolites accumulate preferentially in CSF.
Similar content being viewed by others
References
Amir N, Elpeleg ON, Shalev RS, Christensen E (1989) Glutaric aciduria type I: enzymatic and neuroradiologic investigations of two kindreds.J Pediatr 114: 983–989.
Andreula CF, De Blasi R, Carella A (1991) CT and MR studies of methylmalonic acidemia.Am J Neuroradiol 12: 410–412.
Barth PG, Hoffmann GF, Jaeken J et al (1992)l-2-Hydroxyglutaric acidemia: A novel inherited neurometabolic disease.Ann Neurol 32: 66–71.
Barth PG, Hoffmann GF, Jaeken J et al (1993)l-2-Hydroxyglutaric acidaemia: clinical and biochemical findings in 12 patients and preliminary report onl-2-hydroxyacid dehydrogenase.J Inher Metab Dis 16: 753–761.
Benninger C, Lichter-Konecki U, Schmitt HP, Reichmann H (1990) Isolierter Cytochrom-C-Oxidase-Mangel im Gehirn. In Hanefeld, F, Rating D, Christen HJ, eds.Aktuelle Neuropädiatrie 1989. Heidelberg: Springer Verlag, 217–220.
Brown GK, Haan EH, Kirby DM et al (1988) ‘Cerebral’ lactic acidosis: defects in pyruvate metabolism with profound brain damage and minimal systemic acidosis.Eur J Pediatr 147: 10–14.
Chalmers RA, Lawson AM (1982)Organic Acids In Man. London: Chapman and Hall.
Chang Y-F (1976) Pipecolic acid pathway: The major lysine metabolic route in the rat brain.Biochem Biophys Res Commun 69: 174–180.
Coude M, Kamoun P (1992) Organic acids in post-mortem cerebrospinal fluid.Clin Chim Acta 206: 201–206.
Coude M, Chadefaux B, Charpentier C, Kamoun P (1991) Medium-chain triglycerides: a pitfall in the assay of organic acids in cerebrospinal fluid.J Inher Metab Dis 14: 841.
Cremer JE, Braun LD, Oldendorf WH (1976) Changes during development in transport processes of the blood-brain barrier.Biochim Biophys Acta 448: 633–637.
Cutler RWP, Page L, Galicich J, Watters GV (1968) Formation and absorption of cerebrospinal fluid in man.Brain 91: 707–720.
Dayan AD, Ramsey RB (1984) An inborn error of vitamin B12 metabolism associated with cellular deficiency of coenzyme forms of the vitamin.J Neurol Sci 23: 117–128.
Divry P, Vianey-Liaud C, Gay C, Macabeo V, Rapin F, Echenne B (1988).N-acetylaspartic aciduria: report of three new cases in children with a neurological syndrome associating macrocephaly and leukodystrophy.J Inher Metab Dis 11: 307–308.
Divry P, Vianey-Liaud C, Jakobs C, Ten-Brink HJ, Dutruge J, Gilly R (1990) Sudden infant death syndrome: organic acid profiles in cerebrospinal fluid from 47 children and the occurrence ofN-acetylaspartic acid.J Inher Metab Dis 13: 330–332.
Fenstermacher JD, Patlak CS (1975) The exchange of material between cerebrospinal fluid and brain. In Cserr HF, Fenstermacher JD, Fencl V, eds.Fluid Environment of the Brain. New York: Academic Press, 201–214.
Fishman RA (1980)Cerebrospinal Fluid in Diseases of the Nervous System. Philadelphia: WB Saunders.
Fois A, Cioni M, Balestri P, Bartilini G, Baumgartner R, Bachmann C (1986) Biotinidase deficiency: metabolites in CSF.J Inher Metab Dis 9: 284–285.
Gerrits GP, Trijbels FJ, Monnens LA et al (1989) Reference values for amino acids in cerebrospinal fluid of children determined using ion-exchange chromatography with fluorimetric detection.Clin Chim Acta 182: 271–280.
Gibson KM, Hoffmann G, Sweetman L et al (1988) 4-Hydroxybutyric aciduria in a patient without ataxia or convulsions.Eur J Pediatr 147: 529–531.
Gibson KM, DeVivo DC, Jakobs C (1989) Vigabatrin therapy in a patient with succinic semialdehyde dehydrogenase deficiency.Lancet 2: 1105–1106.
Gibson KM, Aramaki S, Sweetman L et al (1990) Stable isotope dilution analysis of 4-hydroxybutyric acid: an accurate method for quantification in physiological fluids and the prenatal diagnosis of 4-hydroxybutyric aciduria.Biomed Environ Mass Spectrom 19: 89–93.
Goodman SI, Norenberg MD, Shikes RH, Breslich DJ, Moe PG (1977) Glutaric aciduria: biochemical and morphological considerations.J Pediatr 90: 746–750.
Haworth JC, Booth FA, Chudley AE et al (1991) Phenotypic variability in glutaric aciduria type I: Report of fourteen cases in five Canadian Indian kindreds.J Pediatr 118: 52–58.
Hayasaka K, Metoki K, Satoh T, Narisawa K, Tada K, Kawakami T (1982) Comparison of cytosolic and mitochondrial enzyme alteration in the livers of propionic or methylmalonic acidemia: a reduction of cytochrome oxidase activity.Tohoku J Exp Med 137: 329–334.
Hoffmann G, Sweetman L (1987)O-(2,3,4,5,6-Pentafluorobenzyl)oxime-trimethylsilyl ester derivatives for quantitative gas chromatographic-mass spectrometic studies of aldehydes, ketones, and oxoacids in biological fluids.J Chromatogr 421: 336–343.
Hoffmann GF, Sweetman L (1991)O-(2,3,4,5,6-Pentafluorobenzyl)oxime-trimethylsilyl ester derivatives for sensitive identification and quantitation of aldehydes, ketones, and oxoacids in biological fluids.Clin Chim Acta 199: 237–242.
Hoffmann G, Aramaki S, Blum-Hoffmann E, Nyhan WL, Sweetman L (1989) Quantitative analysis for organic acids in biological samples: batch isolation followed by gas chromatographic-mass spectrometric analysis.Clin Chem 35: 587–595.
Hoffmann GF, Hunneman DH, Voss W et al (1990)l-2-Hydroxyglutarazidurie: Eine neue Enzephalopathie mit leukodystrophen Veränderungen. In Hanefeld F, Rating D, Christen HJ, eds.Aktuelle Neuropädiatrie 1989. Heidelberg: Springer Verlag, 139–142.
Hoffmann GF, Trefz FK, Barth P et al (1991) Glutaryl-CoA dehydrogenase deficiency: A distinct encephalopathy.Pediatrics 88: 1194–1203.
Howells DW, Hyland K (1987) Direct analysis of tetrahydrobiopterin in cerebrospinal fluid by high-performance liquid chromatography with redox electrochemistry — Prevention of autooxidation during storage and analysis.Clin Chim Acta 167: 23–30.
Jakobs C, Smit LME, Kneer J, Michael T, Gibson KM (1990) The first adult case with 4-hydroxybutyric aciduria.J Inher Metab Dis 13: 341–344.
Knudsen GM, Paulson OB, Hetz MM (1991) Kinetic analysis of the human blood-brain barrier transport of lactate and its influence by hypercapnia.J Cereb Blood Flow Metab 10: 698–703.
Kusmierz J, DeGeorge JJ, Sweeney D, May C, Rapoport SI (1989) Quantitative analysis of polyols in human plasma and cerebrospinal fluid.J Chromatogr 497: 39–48.
Leibel RL, Shih VE, Goodman SI et al (1980) Glutaric acidemia: a metabolic disorder causing progressive choreoathetosis.Neurology 30: 1163–1168.
Mamelak M (1989) Gammahydroxybutyrate: An endogenous regulator of energy metabolism.Neurosci Biobehav Rev 13: 187–198.
McMillan TA, Gibson KM, Sweetman L, Meyers GS, Green R (1988) Conversation of central nervous system glutaryl-coenzyme A dehydrogenase in fruit-eating bats with glutaric aciduria and deficient hepatic glutaryl-CoA dehydrogenase.J Biol Chem 263: 17258–17261.
Müller J, Vahar-Martiar H (1975) Freie Fettsäuren und Kohlenwasserstoffe im Liquor cerebrospinalis.Z Klin Chem Klin Biochem 13: 183–185.
Nyhan WL (1989) Nonketotic hyperglycinemia. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds.The Metabolic Basis of Inherited Disease, 6th edn. New York: McGraw-Hill, 743–753.
Oldendorf WH (1973) Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids.Am J Physiol 224: 1450–1453.
Ozand PT, Gascon GG (1991) Organic acidurias: A review. Part 1.J Child Neurol 6: 196–219.
Pardridge WM, Connor JD, Crawford IL (1975) Permeability changes in the blood-brain barrier: Causes and consequences.CRC Crit Rev Toxicol 3: 159–199.
Rall DP, Stabenau JR, Zubrod CG (1959) Distribution of drugs between blood and cerebrospinal fluid: general methodology and effect of pH gradients.J Pharmac Exp Ther 125: 185–193.
Rapoport SI (1976)Blood-Brain Barrier in Physiology and Medicine. New York: Raven Press.
Ribes A, Riudor E, Briones P, Christensen E, Campistol J, Millington DS (1992) Significance of bound glutarate in the diagnosis of glutaric aciduria type I.J Inher Metab Dis 15: 367–370.
Roe CR, Gale DS, Millington DS (1988) Evidence for primary CNS ⌉organic acidurias’.SSIEM, Proceedings of the 26th Annual Symposium, Glasgow, Sept. 1988: P68 (abstract).
Saijo T, Naito E, Ito M, Takeda E, Hashimoto T, Kuroda Y (1991) Therapeutic effect of sodium dichloroacetate on visual and auditory hallucinations in a patient with MELAS.Neuropediatrics 22: 166–167.
Sethi KD, Ray R, Roesel RA et al (1989) Adult-onset chorea and dementia with propionic acidemia.Neurology 39: 1343–1345.
Stabler SP, Allen RH, Barrett RE, Savage DG, Lindenbaum J (1991) Cerebrospinal fluid methylmalonic acid levels in normal subjects and patients with cobalamin deficiency.Neurology 41: 1627–1632.
Stokke O, Goodman SI, Moe PG (1976) Inhibition of brain glutamate decarboxylase by glutarate, glutaconate, and beta-hydroxyglutarate: explanation of the symptoms in glutaric aciduria?Clin Chim Acta 66: 411–415.
Sweetman L (1991) Organic acid analysis. In Hommes FA ed.Techniques in Diagnostic Human Biochemical Laboratories: A Laboratory Manual. New York: Wiley-Liss, 143–176.
Tichy J, Skorkovska I (1979) Spectrum of total fatty acids in cerebrospinal fluid determined by gas chromatography.J Chromatogr 162: 185–196.
Weyne J, Leusen I (1975) Lactate in CSF in relation to brain and blood. In Cserr HF, Fenstermacher JD, Fencl V, eds.Fluid Environment of the Brain. New York: Academic Press, 255–276.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoffmann, G.F., Meier-Augenstein, W., Stöckler, S. et al. Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis 16, 648–669 (1993). https://doi.org/10.1007/BF00711898
Issue Date:
DOI: https://doi.org/10.1007/BF00711898